News

Under its distribution agreement with Medafor, Orthovita has the non-exclusive right to sell Vitasure in the spine and orthopedic field in the US, and certain territories outside of

The issued US patent extends the intellectual property surrounding the company’s franchise of oral gallium-containing products that are intended as potential treatment for diseases associated with accelerated bone

Luvox CR was recently approved by the FDA for the treatment of social anxiety disorder (SAD) and obsessive compulsive disorder (OCD) in adult patients. SAD and OCD are

The supplemental new drug application (sNDA) is based on results from a recent study comparing patients who received Risperdal Consta and standard treatment to those who received standard

The interim analysis of 806 patients who completed three months in the study showed dose-related, statistically significant reductions in A1c. The mean changes for patients in the 150mg,

Under the terms of the agreement, Debiopharm will pay Airmid an option fee for signature of the contract. If Debiopharm exercises its exclusive option to license-in the product

Under the terms of the agreement, Rib-X and the Molecular Biology of the Medical Research Council (MRC) will continue to jointly explore the high resolution crystal structure of

This is a single center, randomized, single masked, comparative-group safety and tolerability study of a range of single iontophoretic dose levels with a citrate buffer via the EyeGate

The trial (REO 011) has two components. The first is an open-label, dose-escalating, non-randomized study of Reolysin given intravenously with paclitaxel and carboplatin every three weeks. Standard dosages